Literature DB >> 8689102

Phase II trials in Ta, T1 bladder cancer. The marker tumour concept.

A P van der Meijden1, R R Hall, K H Kurth, C Bouffioux, R Sylvester.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8689102     DOI： 10.1046/j.1464-410x.1996.09002.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  2 in total

1.  Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.

Authors:  Kees Hendricksen; Antoine G van der Heijden; Erik B Cornel; Henk Vergunst; Theo M de Reijke; Erika van Boven; Geert A H J Smits; Rajiv Puri; Sigrid Gruijs; J Alfred Witjes
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

2.  Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer.

Authors:  Remco J Molenaar; Jons W van Hattum; Iris S Brummelhuis; Jorg R Oddens; C Dilara Savci-Heijink; Egbert R Boevé; Saskia A van der Meer; J Fred Witjes; Michael N Pollak; Theo M de Reijke; Johanna W Wilmink
Journal:  BMC Cancer       Date:  2019-11-21       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.